Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Other Non Operating Income (2022 - 2024)

Orchestra BioMed Holdings (OBIO) has disclosed Other Non Operating Income for 2 consecutive years, with -$11000.0 as the latest value for Q1 2024.

  • On a quarterly basis, Other Non Operating Income changed N/A to -$11000.0 in Q1 2024 year-over-year; TTM through Dec 2024 was -$11000.0, a N/A change, with the full-year FY2024 number at -$11000.0, up 99.08% from a year prior.
  • Other Non Operating Income was -$11000.0 for Q1 2024 at Orchestra BioMed Holdings, down from $682000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $682000.0 in Q2 2022 to a low of -$11000.0 in Q1 2024.